Pharmaceutical Manufacturing Market - Global Industry Analysis

Pharmaceutical Manufacturing Market - By Drug Type (Biologics & Biosimilars and Small Medicines), By Drug Development (In-house and Outsourced), By Formulation (Tablets, Injectables, Capsules, Sprays, Suspensions, and Powders), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 27-Jul-2021 Category: Pharmaceutical Report Format : PDF Pages: 120 Report Code: ZMR-6521 Status : Published

The global Pharmaceutical Manufacturing market accrued earnings worth approximately 401.32(USD Billion) in 2020 and is predicted to gain revenue of about 832.11 (USD Billion) by 2028, is set to record a CAGR of nearly 11.32% over the period from 2021 to 2028.

Description

The global Pharmaceutical Manufacturing market accrued earnings worth approximately 401.32(USD Billion) in 2020 and is predicted to gain revenue of about 832.11 (USD Billion) by 2028, is set to record a CAGR of nearly 11.32% over the period from 2021 to 2028. The report offers assessment and analysis of the Pharmaceutical Manufacturing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

 

Pharmaceutical Manufacturing Market: Overview

Pharmaceutical manufacturing is the method of industrial-scale synthesizing of pharma drugs and it is also a part & parcel of pharma sector. The procedure of drug production also termed as pharmaceutical manufacturing is divided into number of unit functions including milling, coating, granulation, and tablet pressing. Furthermore, pharma sector has undergone a humongous change with evolution of novel & cost-efficient techniques along with introducing new approaches in pharma manufacturing industry. Surge in funding of pharma manufacturing processes in pharmaceutical industry will translate into enlarged scope of pharmaceutical manufacturing industry in upcoming years. Apart from this, pharma production downtime & output of product wastage are minimized with execution of AI & robotic systems.

Pharmaceutical Manufacturing Market: Growth Drivers

Growing demand for paperless and smart functions in drug production will drive pharmaceutical manufacturing market trends. In addition to this, consistent growth in domain of personalized medicine has led to exploration & development of patient-centric models, thereby further creating new growth avenues for pharmaceutical manufacturing business. Apparently, altering landscape of small drugs in drug potency terms, medicine complexity, business makeup, and production trends is predicted to aid demand for small drugs in pharma sector. This, in turn, will prompt expansion of pharmaceutical manufacturing industry over forecast period.

Moreover, increase in medicine approvals by regulatory authorities such as the U.S. FDA is projected to boost drug manufacturing procedures, thereby completely transforming the phase of growth of pharmaceutical manufacturing industry. Additionally, a massive rise in funding of clinical experiments by pharma firms & surge in research activities on new drug development will steer growth of pharmaceutical manufacturing market.

Global Pharmaceutical Manufacturing Market

Regional Landscape

North America To Contribute Majorly Towards Global Market Size By 2028

The expansion of pharmaceutical manufacturing industry in North America during 2021-2028 is due to huge number of strategic alliances between pharmaceutical firms in countries such as Canada and the U.S. In addition to this, rise in spending on prescribed medicines in the U.S. will spur regional market size within next couple of years. Apart from this, increase in number of research projects associated with drug efficiency testing activities in Canada and the U.S. will expedite regional market value in ensuing years.

Competitive Landscape

Key players profiled in report and leveraging industry landscape are Novartis AG, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Sanofi SA, Johnson & Johnson, Roche Holding AG, AbbVie, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Gilead Sciences, Inc.,  and Bristol Myers Squibb Company.

The global Pharmaceutical Manufacturing Market is segmented as follows:

By Drug Type

  • Biologics & Biosimilars
  • Small Medicines

By Drug Development

  • In-house  
  • Outsourced

By Formulation

  • Tablets
  • Injectables
  • Capsules
  • Sprays
  • Suspensions
  • Powders

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
    • 2.2. Pharmaceutical Manufacturing Market: Snapshot
  • Chapter 3. Global Pharmaceutical Manufacturing Market– Industry Analysis
    • 3.1. Pharmaceutical Manufacturing Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Escalating demand for paperless and smart operations in drug production will scale up pharmaceutical manufacturing market growth.
      • 3.2.2. Constant & seamless growth of personalized medicine market has led to exploration of patient-centric prototypes, thereby generating new growth opportunities for pharmaceutical manufacturing sector.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Drug Type
      • 3.4.2. Market attractiveness analysis By Drug Development
      • 3.4.3. Market attractiveness analysis By Formulation
  • Chapter 4. Global Pharmaceutical Manufacturing Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Pharmaceutical Manufacturing Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Pharmaceutical Manufacturing Market– Drug Type Analysis
    • 5.1. Global Pharmaceutical Manufacturing Market overview: By Drug Type
      • 5.1.1. Global Pharmaceutical Manufacturing Market share, By Drug Type, 2020 and 2028
    • 5.2. Biulogics & Biosimilars
      • 5.2.1. Global Pharmaceutical Manufacturing Market by Biulogics & Biosimilars, 2018–2028(USD Billion)
    • 5.3. Small Medicines
      • 5.3.1. Global Pharmaceutical Manufacturing Market by Small Medicines, 2018–2028(USD Billion)
  • Chapter 6. Global Pharmaceutical Manufacturing Market– Drug Development Analysis
    • 6.1. Global Pharmaceutical Manufacturing Market overview: By Drug Development
      • 6.1.1. Global Pharmaceutical Manufacturing Market share, By Drug Development, 2020 and 2028
    • 6.2. In-house
      • 6.2.1. Global Pharmaceutical Manufacturing Market by In-house , 2018–2028(USD Billion)
    • 6.3. Outsourced
      • 6.3.1. Global Pharmaceutical Manufacturing Market by Outsourced, 2018–2028(USD Billion)
  • Chapter 7. Global Pharmaceutical Manufacturing Market– Formulation Analysis
    • 7.1. Global Pharmaceutical Manufacturing Market overview: By Formulation
      • 7.1.1. Global Pharmaceutical Manufacturing Market share, By Formulation, 2020 and 2028
    • 7.2. Tablets
      • 7.2.1. Global Pharmaceutical Manufacturing Market by Tablets , 2018–2028(USD Billion)
    • 7.3. Injectables
      • 7.3.1. Global Pharmaceutical Manufacturing Market by Injectables, 2018–2028(USD Billion)
    • 7.4. Capsules
      • 7.4.1. Global Pharmaceutical Manufacturing Market by Capsules, 2018–2028(USD Billion)
    • 7.5. Sprays
      • 7.5.1. Global Pharmaceutical Manufacturing Market by Sprays, 2018–2028(USD Billion)
    • 7.6. Suspensions
      • 7.6.1. Global Pharmaceutical Manufacturing Market by Suspensions, 2018–2028(USD Billion)
    • 7.7. Powders
      • 7.7.1. Global Pharmaceutical Manufacturing Market by Powders, 2018–2028(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Novartis AG
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfulio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Pfizer, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfulio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. AstraZeneca
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfulio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Merck & Co., Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfulio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Sanofi SA
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfulio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Johnson & Johnson
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfulio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Roche Hulding AG
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfulio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. AbbVie, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfulio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Eli Lilly and Company
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfulio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Sun Pharmaceutical Industries Limited
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfulio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. Bristul Myers Squibb Company
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfulio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development
    • 8.12. Gilead Sciences, Inc.
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Product Portfulio
      • 8.12.4. Business Strategy
      • 8.12.5. Recent Development
    • 8.13. Takeda Pharmaceuticals, Inc.
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Product Portfulio
      • 8.13.4. Business Strategy
      • 8.13.5. Recent Development
    • 8.14. Novo Nordisk A/S
      • 8.14.1. Overview
      • 8.14.2. Financials
      • 8.14.3. Product Portfulio
      • 8.14.4. Business Strategy
      • 8.14.5. Recent Development
    • 8.15. Cipla Limited
      • 8.15.1. Overview
      • 8.15.2. Financials
      • 8.15.3. Product Portfulio
      • 8.15.4. Business Strategy
      • 8.15.5. Recent Development

Methodology


Frequently Asked Questions

Growing demand for paperless and smart functions in drug production will drive pharmaceutical manufacturing market trends. In addition to this, consistent growth in domain of personalized medicine has led to exploration & development of patient-centric models, thereby further creating new growth avenues for pharmaceutical manufacturing business. Apparently, altering landscape of small drugs in drug potency terms, medicine complexity, business makeup, and production trends is predicted to aid demand for small drugs in pharma sector. This, in turn, will prompt expansion of pharmaceutical manufacturing industry over forecast period.

Moreover, increase in medicine approvals by regulatory authorities such as the U.S. FDA is projected to boost drug manufacturing procedures, thereby completely transforming the phase of growth of pharmaceutical manufacturing industry. Additionally, a massive rise in funding of clinical experiments by pharma firms & surge in research activities on new drug development will steer growth of pharmaceutical manufacturing market.

According to Zion market research report, the global Pharmaceutical Manufacturing market accrued earnings worth approximately 401.32(USD Billion) in 2020 and is predicted to gain revenue of about 832.11 (USD Billion) by 2028, is set to record a CAGR of nearly 11.32% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is subject to huge number of strategic alliances between pharmaceutical firms in countries such as Canada and the U.S. In addition to this, rise in spending on prescribed medicines in the U.S. will spur regional market size within next couple of years. Apart from this, increase in number of research projects associated with drug efficiency testing activities in Canada and the U.S. will expedite regional market value in ensuing years.   

The key market participants include Novartis AG, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Sanofi SA, Johnson & Johnson, Roche Holding AG, AbbVie, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Gilead Sciences, Inc.,  and Bristol Myers Squibb Company.

 

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social